Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Creative Medical Technology Holdings (CELZ) over the last 17 years, with Q3 2025 value amounting to $5.4 million.

  • Creative Medical Technology Holdings' Cash & Equivalents fell 1413.52% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year decrease of 1413.52%. This contributed to the annual value of $5.9 million for FY2024, which is 7134.78% up from last year.
  • As of Q3 2025, Creative Medical Technology Holdings' Cash & Equivalents stood at $5.4 million, which was down 1413.52% from $6.5 million recorded in Q2 2025.
  • Creative Medical Technology Holdings' 5-year Cash & Equivalents high stood at $22.9 million for Q2 2022, and its period low was $158588.0 during Q2 2021.
  • Moreover, its 5-year median value for Cash & Equivalents was $6.5 million (2025), whereas its average is $7.4 million.
  • In the last 5 years, Creative Medical Technology Holdings' Cash & Equivalents skyrocketed by 1431701.83% in 2022 and then plummeted by 8255.07% in 2023.
  • Creative Medical Technology Holdings' Cash & Equivalents (Quarter) stood at $10.7 million in 2021, then decreased by 22.41% to $8.3 million in 2022, then tumbled by 58.33% to $3.5 million in 2023, then surged by 71.35% to $5.9 million in 2024, then dropped by 9.51% to $5.4 million in 2025.
  • Its Cash & Equivalents stands at $5.4 million for Q3 2025, versus $6.5 million for Q2 2025 and $7.7 million for Q1 2025.